Stock listing
Turquoise:BIOVZ BioVersys AG Share Price
UK listing (Turquoise) of BioVersys AG · home listing SIX Swiss:BIOV
Follow BioVersys AG into a list and get an email when it puts out news.
Home listing price · SIX:BIOV
23.20 CHF -0.30 (-1.3%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:BIOV
- Day range
- 23.20 – 24.80 CHFOct 30, 2026
- Volume
- 4,041 sharesOct 30, 2026
- Market cap
- 135.8M CHFAt the close on Oct 30, 2026 · price × 5.85M shares outstanding
- 52-week range
- 21.20 – 30.70 CHFLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 53,496 CHFMedian day 1,576 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:BIOV · Home | 23.20 CHF | -0.30 (-1.3%) | 4,041 | 23.20 | 24.80 | 23.20 | 23.50 | Close on Oct 30, 2026 |
| Frankfurt:W33 | €25.20 EUR | 0.00 (0.0%) | — | €25.00 | €25.20 | €25.00 | €25.20 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · SIX:BIOV · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 23.20 | -0.30 | -1.3% | 23.20 | 24.80 | 23.20 | 4,041 | |
| 23.50 | +0.10 | +0.4% | 23.40 | 24.90 | 23.20 | 2,978 | |
| 23.40 | -0.20 | -0.8% | 24.30 | 24.40 | 23.40 | 1,576 | |
| 23.60 | -0.90 | -3.7% | 23.60 | 23.90 | 23.40 | 2,252 | |
| 24.50 | -0.20 | -0.8% | 23.40 | 24.70 | 23.40 | 3,310 | |
| 24.70 | +1.40 | +6.0% | 24.70 | 24.70 | 23.40 | 2,228 | |
| 23.30 | -1.50 | -6.0% | 24.80 | 24.80 | 23.30 | 5,974 | |
| 24.80 | +0.40 | +1.6% | 24.80 | 24.80 | 24.30 | 948 | |
| 24.40 | -0.40 | -1.6% | 24.80 | 24.80 | 24.40 | 475 | |
| 24.80 | -0.60 | -2.4% | 24.70 | 24.80 | 24.20 | 1,623 | |
| 25.40 | -0.50 | -1.9% | 25.90 | 25.90 | 24.90 | 1,464 | |
| 25.90 | 0.00 | 0.0% | 25.80 | 25.90 | 25.40 | 1,166 | |
| 25.90 | +0.80 | +3.2% | 24.70 | 25.90 | 24.50 | 2,302 | |
| 25.10 | -0.30 | -1.2% | 25.10 | 25.50 | 24.80 | 4,090 | |
| 25.40 | -1.10 | -4.2% | 25.10 | 26.40 | 25.10 | 5,397 | |
| 26.50 | 0.00 | 0.0% | 25.70 | 26.50 | 25.70 | 301 | |
| 26.50 | -0.30 | -1.1% | 26.80 | 26.80 | 26.40 | 289 | |
| 26.80 | +0.80 | +3.1% | 25.60 | 26.90 | 25.60 | 312 | |
| 26.00 | -0.90 | -3.3% | 25.60 | 26.50 | 25.60 | 1,404 | |
| 26.90 | -0.10 | -0.4% | 27.00 | 27.00 | 25.50 | 392 | |
| 27.00 | -0.20 | -0.7% | 27.40 | 27.40 | 27.00 | 1,245 | |
| 27.20 | -0.20 | -0.7% | 25.50 | 27.40 | 25.50 | 257 | |
| 27.40 | +0.90 | +3.4% | 26.80 | 27.40 | 25.30 | 360 | |
| 26.50 | +0.50 | +1.9% | 26.00 | 26.50 | 25.10 | 994 | |
| 26.00 | -0.20 | -0.8% | 25.70 | 26.00 | 25.40 | 151 | |
| 26.20 | +0.80 | +3.1% | 27.30 | 27.30 | 26.00 | 2,139 | |
| 25.40 | +0.10 | +0.4% | 25.30 | 25.80 | 25.00 | 2,671 | |
| 25.30 | -1.20 | -4.5% | 26.70 | 26.80 | 25.30 | 3,400 | |
| 26.50 | -0.10 | -0.4% | 26.60 | 28.40 | 26.50 | 2,432 | |
| 26.60 | -2.00 | -7.0% | 28.40 | 28.40 | 26.60 | 3,466 | |
| 28.60 | +0.50 | +1.8% | 28.00 | 28.60 | 28.00 | 4,074 | |
| 28.10 | +1.10 | +4.1% | 27.00 | 28.10 | 26.90 | 449 | |
| 27.00 | -1.20 | -4.3% | 28.10 | 28.10 | 27.00 | 2,798 | |
| 28.20 | +1.20 | +4.4% | 28.40 | 28.40 | 27.00 | 2,071 | |
| 27.00 | -0.20 | -0.7% | 27.40 | 27.40 | 26.50 | 4,489 | |
| 27.20 | +0.70 | +2.6% | 26.90 | 27.20 | 26.60 | 3,141 | |
| 26.50 | -0.90 | -3.3% | 27.00 | 27.00 | 26.50 | 4,103 | |
| 27.40 | -1.10 | -3.9% | 28.50 | 28.50 | 26.80 | 2,315 | |
| 28.50 | +0.50 | +1.8% | 28.00 | 28.50 | 28.00 | 1,398 | |
| 28.00 | 0.00 | 0.0% | 28.20 | 28.50 | 28.00 | 3,206 | |
| 28.00 | +0.10 | +0.4% | 27.90 | 28.00 | 27.30 | 1,972 | |
| 27.90 | -0.30 | -1.1% | 28.00 | 28.00 | 26.50 | 4,711 | |
| 28.20 | +3.30 | +13.3% | 26.80 | 28.50 | 26.80 | 12,773 | |
| 24.90 | +0.10 | +0.4% | 26.00 | 26.00 | 24.50 | 842 | |
| 24.80 | -2.00 | -7.5% | 26.00 | 26.00 | 24.80 | 1,167 | |
| 26.80 | +2.10 | +8.5% | 25.80 | 26.80 | 25.40 | 2,359 | |
| 24.70 | -0.60 | -2.4% | 25.40 | 25.40 | 24.30 | 2,517 | |
| 25.30 | +0.10 | +0.4% | 25.10 | 25.30 | 24.80 | 430 | |
| 25.20 | +0.40 | +1.6% | 25.00 | 25.40 | 25.00 | 2,478 | |
| 24.80 | 0.00 | 0.0% | 25.00 | 25.30 | 24.80 | 311 | |
| 24.80 | -0.40 | -1.6% | 25.00 | 25.00 | 24.80 | 1,152 | |
| 25.20 | +0.10 | +0.4% | 25.00 | 25.60 | 25.00 | 2,983 | |
| 25.10 | -1.60 | -6.0% | 26.00 | 26.30 | 25.10 | 885 | |
| 26.70 | +0.20 | +0.8% | 26.00 | 26.70 | 26.00 | 192 | |
| 26.50 | 0.00 | 0.0% | 26.70 | 26.80 | 26.00 | 520 | |
| 26.50 | 0.00 | 0.0% | 26.00 | 26.50 | 25.90 | 2,279 | |
| 26.50 | +0.30 | +1.1% | 27.20 | 27.20 | 26.20 | 576 | |
| 26.20 | -1.00 | -3.7% | 26.10 | 27.50 | 26.00 | 3,180 | |
| 27.20 | -0.30 | -1.1% | 26.50 | 27.20 | 26.00 | 939 | |
| 27.50 | 0.00 | 0.0% | 27.00 | 27.50 | 26.40 | 2,366 | |
| 27.50 | +1.00 | +3.8% | 26.50 | 27.50 | 26.40 | 1,362 | |
| 26.50 | +0.50 | +1.9% | 26.00 | 26.80 | 26.00 | 1,058 | |
| 26.00 | -0.80 | -3.0% | 26.50 | 26.80 | 26.00 | 1,572 | |
| 26.80 | 0.00 | 0.0% | 26.50 | 26.80 | 26.50 | 73 | |
| 26.80 | +0.20 | +0.8% | 26.60 | 26.80 | 26.50 | 243 | |
| 26.60 | -0.80 | -2.9% | 26.70 | 27.40 | 26.60 | 317 | |
| 27.40 | +0.40 | +1.5% | 27.20 | 27.40 | 26.70 | 85 |
- Ticker
- Turquoise:BIOVZ
- Asset type
- Stock
- Exchange
- Turquoise
- Currency
- CHF
What changed lately
Latest news release · Sep 9, 2026
BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations funded into 2028
Latest deck · Sep 9, 2026
Q3 2026 Earnings Presentation
Earnings · 46 slides
Latest news
BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations funded into 2028
Sep 9, 2026
Closed 27.40 (-3.9%) on Sep 9, 2026
BioVersys to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026
Closed 28.00 (+0.4%) on Sep 4, 2026
BioVersys granted Fast-Track Designation from US FDA for BV100
Sep 2, 2026
Closed 28.20 (+13.3%) on Sep 2, 2026
BioVersys to report its half-year 2026 financial results, provide a business update and host a conference call
Aug 26, 2026
Closed 25.30 (+0.4%) on Aug 26, 2026
BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
Apr 30, 2026
Closed 27.50 (-3.2%) on May 4, 2026
BioVersys completes BV100 Phase 1 clinical trial in China
Apr 22, 2026
Closed 29.00 (-3.0%) on Apr 22, 2026
BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
Apr 16, 2026
Closed 29.50 (+1.7%) on Apr 16, 2026
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
Apr 15, 2026
Closed 29.00 (+3.6%) on Apr 15, 2026
Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)
Apr 13, 2026
Closed 27.00 (+1.9%) on Apr 13, 2026
BioVersys Issues Invitation to its 2026 Annual General Meeting of Shareholders
Apr 7, 2026
Closed 26.50 (-10.5%) on Apr 7, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 46 slides · Sep 9, 2026
H1 2026 Earnings Presentation
Earnings · 21 slides · Sep 9, 2026
FY2025 Earnings Presentation
Earnings · 27 slides · Mar 18, 2026
BioVersys AG on 6ix
- News releases
- 20 in the last 12 months · 24 in all · newest Sep 9, 2026 · oldest 2025
- Decks
- 3 decks · latest Sep 9, 2026
Where BioVersys AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:BIOV · Home listing | SIX Swiss | Switzerland | CHF |
| Frankfurt:W33 | Frankfurt | Germany | EUR |
| Turquoise:BIOVZ · This page | Turquoise | United Kingdom | CHF |
Log in to ask 6ix AI your own questions about BioVersys AG.